• Legionella Antigen, Urine
  • Immunophenotypic Analysis of Tissues by Flow Cytometry
  • Parvovirus B19 Antibody, IgM
  • MDA, Urine
  • Prostate Specific Antigen (PSA), Total
  • 11-Deoxycortisol, Serum
  • Collagen Type II, Antibody
  • Reticulocyte Count
  • Decipher Bladder Cancer Genomic Profiling
  • Cytochrome P450 2C19 (CYP2C19) Genotyping
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
Medical Test

Clinical Utility
Access to Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants is restricted.
Loading...